Immunohistologic analysis of PTP1B protein expression in hematolymphoid neoplasia
Lymphoma subtype . | Total positive* . | % positive . |
---|---|---|
B-cell lymphoma (N = 339) | ||
Follicular lymphoma | ||
Grade 1 | 0/48 | 0 |
Grade 2 | 8/59 | 14 |
Grade 3 | 20/68 | 29 |
Diffuse large B-cell lymphoma | 46/80 | 58 |
Burkitt lymphoma | 0/4 | 0 |
Marginal zone lymphoma | 7/21 | 33 |
Mantle cell lymphoma | 3/18 | 17 |
Small lymphocytic lymphoma/CLL | 2/32 | 6 |
Precursor B-lymphoblastic lymphoma | 1/7 | 14 |
Plasma cell neoplasms | 0/2 | 0 |
T-cell lymphoma (N = 35) | ||
Precursor T-lymphoblastic lymphoma | 0/11 | 0 |
Peripheral T-cell lymphoma | 10/16 | 62 |
Anaplastic large cell lymphoma | 1/5 | 20 |
NK lymphoma | 0/3 | 0 |
Histiocytic neoplasms (N = 7) | ||
Langerhan cell histiocytosis | 3/4 | 75 |
Rosai-Dorfman disease | 3/3 | 100 |
Lymphoma subtype . | Total positive* . | % positive . |
---|---|---|
B-cell lymphoma (N = 339) | ||
Follicular lymphoma | ||
Grade 1 | 0/48 | 0 |
Grade 2 | 8/59 | 14 |
Grade 3 | 20/68 | 29 |
Diffuse large B-cell lymphoma | 46/80 | 58 |
Burkitt lymphoma | 0/4 | 0 |
Marginal zone lymphoma | 7/21 | 33 |
Mantle cell lymphoma | 3/18 | 17 |
Small lymphocytic lymphoma/CLL | 2/32 | 6 |
Precursor B-lymphoblastic lymphoma | 1/7 | 14 |
Plasma cell neoplasms | 0/2 | 0 |
T-cell lymphoma (N = 35) | ||
Precursor T-lymphoblastic lymphoma | 0/11 | 0 |
Peripheral T-cell lymphoma | 10/16 | 62 |
Anaplastic large cell lymphoma | 1/5 | 20 |
NK lymphoma | 0/3 | 0 |
Histiocytic neoplasms (N = 7) | ||
Langerhan cell histiocytosis | 3/4 | 75 |
Rosai-Dorfman disease | 3/3 | 100 |
Cases were scored positive if more than 30% of lymphoma cells stained for PTP1B.